Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
75 hedge funds and large institutions have $6.3M invested in Ampio Pharmaceuticals Inc. in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 15 closing their positions.
756% more call options, than puts
Call options by funds: $137K | Put options by funds: $16K
45% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 11
7% less funds holding
Funds holding: 81 → 75 (-6)
21% less capital invested
Capital invested by funds: $7.96M → $6.3M (-$1.66M)
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMC
Private Capital Management (Colorado)
Denver,
Colorado
|
+$290K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$290K |
| 3 |
WWM
Western Wealth Management
Golden,
Colorado
|
+$233K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$176K |
| 5 |
Renaissance Technologies
New York
|
+$77.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$2.04M |
| 2 |
Millennium Management
New York
|
-$776K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$392K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$234K |
| 5 |
Goldman Sachs
New York
|
-$191K |
AMPE Hedge Fund Activity: Q3 2019 in Review
75 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2019, worth a combined $6.3M — down 21% from $7.96M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of AMPE and 9 opened new positions — a net loss of 6 holders — while 11 trimmed existing stakes and 16 added.
The largest buyer was Private Capital Management (Colorado), opening a new position worth an estimated $290K. The largest seller was Sabby Management, exiting entirely with an estimated $2.04M sold.
- 75 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2019, down from 81 in Q2 2019.
- Funds reported $6.3M of Ampio Pharmaceuticals Inc. stock for Q3 2019, down 21% quarter-over-quarter.
- 9 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2019 and 15 closed out, a net change of -6 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q3 2019 was Private Capital Management (Colorado), an estimated $290K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q3 2019 was Sabby Management, an estimated $2.04M sold.
Based on aggregated 13F filings for Q3 2019.